Medicare
The AHA shared a statement with the media in response to a report released May 7 by Families USA.
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D beneficiaries for $50 per month beginning July 1 this year through Dec. 31, 2027.
AHA comments on the Centers for Medicare & Medicaid Services’ revised Medicare Part C and D Reporting requirements.
The Centers for Medicare & Medicaid Services has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab Fee Schedule Module. CMS has created a guide for hospital outreach laboratories to determine their applicable status.
Sens. Chuck Grassley, R-Iowa, and Michael Bennet, D-Colo., April 30 introduced the Rural Community Hospital Demonstration Reauthorization Act, legislation that would grant a five-year extension to a Medicare payment model for rural hospitals.
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-designated Class II and Class III devices for Medicare beneficiaries.
The latest report from Paragon, which has targeted hospitals, relies on a long list of distorted and debunked arguments.
The interim final rule released April 20 by the Department of Justice regarding delayed compliance deadlines for nondiscrimination regulations does not address regulatory compliance deadlines under Section 504 of the Rehabilitation Act. Specifically, compliance deadlines for the Department of…
The AHA and dozens of other organizations April 14 sent a letter of support to Reps. Suzan DelBene, D-Wash., and Mike Kelly, R-Pa., for their introduction of the Chronic Care Management Improvement Act.
We, the undersigned organizations, strongly endorse the Chronic Care Management Improvement Act of 2026 to ensure that more chronically ill Medicare patients receive access to high-quality care.